Copyright
©2014 Baishideng Publishing Group Inc.
World J Nephrol. Aug 6, 2014; 3(3): 107-113
Published online Aug 6, 2014. doi: 10.5527/wjn.v3.i3.107
Published online Aug 6, 2014. doi: 10.5527/wjn.v3.i3.107
Table 4 Multivariable analysis of risk factors for acute rejection
| Hazard ratio | 95%CI | P value | |
| Race (black vs non-black ) | 2.68 | 1.67-6.73 | 0.032 |
| Donor (living vs deceased) | 0.32 | 0.11-0.94 | 0.038 |
| Ketoconazole (yes vs no) | 2.33 | 1.33-4.07 | 0.003 |
| Delayed graft function (yes vs no) | 2.14 | 1.22-3.73 | 0.008 |
| Infection (yes vs no) | 1.89 | 1.04-3.48 | 0.038 |
| Tacrolimus dose (mg/d) in 2nd month | 0.89 | 0.75-0.96 | 0.041 |
- Citation: Khan E, Killackey M, Kumbala D, LaGuardia H, Liu YJ, Qin HZ, Alper B, Paramesh A, Buell J, Zhang R. Long-term outcome of ketoconazole and tacrolimus co-administration in kidney transplant patients. World J Nephrol 2014; 3(3): 107-113
- URL: https://www.wjgnet.com/2220-6124/full/v3/i3/107.htm
- DOI: https://dx.doi.org/10.5527/wjn.v3.i3.107